Atlas Trials

Efficacy and Safety of BCD-063 and Copaxone-Teva in Patients With Relapsing-Remitting Multiple Sclerosis

Clinical trial NCT02753088 · COMPLETED

Trial details

NCT number
NCT02753088
Sponsor
Biocad
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Relapsing-remitting Multiple Sclerosis
Start date
2013-10-01
Primary completion
2015-11-01
Enrollment
158

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.